M
Power Law company profile
MacroGenics
Biotech & Life Sciences · Rockville, United States · Founded 2000 · IPO 2013 Unicorn
Valuation
$34M
Market cap · Apr/2026
Revenue
$150M
Latest reported FY
Global footprint
Where MacroGenics has talent and traffic
Web traffic by country
9.2K
monthly visits
across markets
across markets
🇺🇸 United States81.5%
🇮🇳 India12%
🇨🇦 Canada6.5%
🏳️ Russian Federation0%
Patent intelligence
$138M patent portfolio · 70 active families
Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.
Estimated portfolio value
$138M
400.6% of market cap · 19.8× smaller than top peer Illumina ($2.7B)
70 active patent families
Where MacroGenics innovates
Human cancerCancer researchCarcinosisDiseaseMolecular biology
Below peer median on Strategic
Quality vs same-sector peers
MacroGenics on the five Patsnap quality dimensions
MacroGenics in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.
Compare against
Patent quality scores (0–100)
Source: Dealroom Patent Intelligence · PatsnapTech-focus vs peers
Where MacroGenics concentrates inside the peer cluster
Axes are the most-shared Patsnap topics across MacroGenics and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).
Compare against
Top-topic prominence (rank inverted, 0–100)
Source: Dealroom Patent Intelligence · Patsnap top-10 topics per companySee MacroGenics on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.